Form 8-K - Current report:
SEC Accession No. 0001600132-20-000006
Filing Date
2020-01-29
Accepted
2020-01-29 16:24:40
Documents
1
Period of Report
2020-01-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjanuary2020reversestoc.htm 8-K 37117
  Complete submission text file 0001600132-20-000006.txt   38296
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 20558490
SIC: 2834 Pharmaceutical Preparations